Disposable blood bags are biomedical devices used to collect, transport, and transfuse blood and its components. They are manufactured of biocompatible PVC that has been combined with the appropriate additives to ensure that they do not react with blood elements. Because glass bottles can break at any time, they must be painstakingly washed, rinsed, and autoclaved. As a result, disposable blood bags are favoured over glass bottles. Disposable blood bags also aid in the separation of blood components used in the treatment of various blood illnesses, such as plasma, platelets, and cryoprecipitate.

The growing prevalence of blood-related illnesses and the growing demand for blood collection and transfer bags are projected to drive growth in the global disposable blood bag market over the projected period. According to the National Heart, Lung, and Blood Institute in the United States, blood issues impact millions of people each year. Haemophilia, anaemias, venous thromboembolism, and other bleeding disorders all affect red and white blood cells, platelets, bone marrow, vascular endothelium, and plasma proteins. These conditions can be passed down via families or acquired. These issues can cause abnormal blood cell activity, which can lead to disease or negatively affect everyone's health.

Transmitting HIV, hepatitis B or C, and sepsis is more likely when plastic bags are used carelessly or are contaminated. Hepatitis C, for example, is the most common chronic bloodborne disease transmitted through blood transfusion. These risks are heightened in many low-income countries that lack a complete healthcare infrastructure for blood collection, storage, and delivery. This is expected to slow global disposable bag market growth throughout the forecast year.

The global disposable blood bag sector is likely to benefit from the COVID-19 outbreak. In the COVID-19 pandemic, passive immunotherapy using whole blood or plasma from recovered patients has emerged as a feasible infection strategy. Transfusing neutralising antibodies via convalescent blood is a common practice in hospitals around the world. As a result, the growing adoption of immunotherapy utilising blood and plasma increases the usage of blood bags, which is likely to drive market growth.

The market study provides market data by competitive landscape, revenue analysis, market segments and detailed analysis of key market players such as; Fresenius SE & Co. KGaA, Grifols S.A., Haemonetics Corporation, HLL Lifecare Limited, INNVOL Medical India Limited, Maco Pharma, Neo medic International, Poly Medi cure Limited, Span Healthcare Private Limited, Teleflex Incorporated.

By Type: Based on the Type, Global Disposable Blood Bags Market is segmented as; Double Blood Bags, Quadruple Blood Bags, Single Blood Bags, Triple Blood Bags.

By End User: Based on the End User, Global Disposable Blood Bags Market is segmented as; Blood Banks, Home Healthcare, Hospitals, NGOs.

By Distribution Channel: Based on the Distribution Channel, Global Disposable Blood Bags Market is segmented as; Private Sales, Tender Sales.

By Region: This research also includes data for North America, Asia-Pacific, Latin America, Middle East & Africa and Europe.

This study also encompasses various drivers and restraining factors of this market for the forecast period. Various growth opportunities are also discussed in the report.